Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Yuanda Biopharmaceutical is a Chinese pharmaceutical company specializing in the research, development, and production of biological products, with a primary focus on human vaccines. As a subsidiary of China Grand Pharmaceutical and Healthcare Holdings, the company operates a large-scale manufacturing base in Zhengzhou, Henan Province. Its flagship product is the Freeze-dried Human Rabies Vaccine (Vero Cell), which is widely distributed across the Chinese market. The company maintains high-standard GMP-certified facilities and is integrated into the broader Grand Pharma ecosystem to leverage R&D and commercialization synergies. Henan Yuanda continues to expand its portfolio within the infectious disease space, emphasizing quality control and technological upgrades in vaccine production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Yuanda Biopharmaceutical.